Skip to content

Noninvasive Mapping Before Surgical Ablation

The Use of Beat-to-Beat Noninvasive 3D Mapping to Study Patients Candidates for Concomitant Surgical Ablation for Persistent and Long-standing Persistent Atrial Fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06803615
Acronym
NIMSA
Enrollment
51
Registered
2025-01-31
Start date
2017-01-13
Completion date
2026-01-31
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Keywords

Atrial Fibrillation, Electrocardiographic Imaging, Noninvasive Mapping, Surgical Ablation

Brief summary

The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.

Interventions

Electrocardiographic imaging is an electrophysiological mapping technique which is used to noninvasively map cardiac arrhythmias.

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* legal age (18-90a) * life expectancy \> 2 years * patients suffering from persistent and long standing atrial fibrillation * scheduled for concomitant surgical ablation * possibility to follow-up * given informed consent

Exclusion criteria

* vulnerable patient groups * pregnancy * any previous surgical ablation * acute surgical indications * any physical condition that leads to a life expectancy of less than two years * any contraindication to the treatments necessary for the trial's conduction as e.g. * known allergic reaction to contrast agent * known allergic reaction to antiarrhythmic drugs * claustrophobia or anxiety in small spaces * severe renal impairment * unmanageable hyperthyroidism * participation in any other clinical trial that either excludes enrolment or may be a confounding factor to results * voluntary retention

Design outcomes

Primary

MeasureTime frameDescription
The patients electrophysiological mapping results acquired with ECGI will be analyzed: Number and distribution of rotor and focal activities will be measured.Prior to the planned procedure.The primary objective of this study is to measure the patients electrophysiological mapping results acquired with ECGI, namely the number and distribution of focal and rotor activities.

Other

MeasureTime frameDescription
Freedom from AF during 12 and 24 months of follow-up.From surgery until 24 months after the procedure.A pre-specified outcome measure is to measure freedom from AF during 12 and 24 months of follow-up. The impact of the preoperative mapping results and the applied respective ablation technique will be analyzed.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026